THE DEAL, AT A GLANCE
From the announcementGlasgow biopharma Mironid
01Who is involvedBacked by Scottish National Investment Bank, the Series B will goFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedGlasgow biopharma Mironid raised Series B, announced 2026-08-10From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersMironid's $39.9M Series B is a mid-market financing signal within the Capvizr FinTech category, matching the 50th percentile of tracked round sizes despite the company…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Glasgow biopharma Mironid · Financing Record
Explore source-linked visual explanations for Glasgow biopharma Mironid. Unsupported claims are withheld while source review continues.
Record 9947 · Recorded date: 2026-08-10
Explore company records →